Elanco Animal Health Incorporated ELAN
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 5.15B | 5.02B | 4.89B | 4.72B | 4.59B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.15B | 5.02B | 4.89B | 4.72B | 4.59B |
| Cost of Revenue | 2.26B | 2.24B | 2.20B | 2.12B | 2.07B |
| Gross Profit | 2.89B | 2.78B | 2.69B | 2.59B | 2.52B |
| SG&A Expenses | 1.55B | 1.51B | 1.46B | 1.42B | 1.39B |
| Depreciation & Amortization | 560.00M | 556.00M | 553.00M | 543.00M | 534.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.75B | 4.68B | 4.59B | 4.46B | 4.34B |
| Operating Income | 397.00M | 340.00M | 307.00M | 259.00M | 247.00M |
| Income Before Tax | -92.00M | -166.00M | -197.00M | -224.00M | -16.00M |
| Income Tax Expenses | 55.00M | 33.00M | 45.00M | 8.00M | -52.00M |
| Earnings from Continuing Operations | -147.00 | -199.00 | -242.00 | -232.00 | 36.00 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -147.00M | -199.00M | -242.00M | -232.00M | 36.00M |
| EBIT | 397.00M | 340.00M | 307.00M | 259.00M | 247.00M |
| EBITDA | 1.07B | 1.01B | 970.00M | 908.00M | 882.00M |
| EPS Basic | -0.30 | -0.40 | -0.49 | -0.47 | 0.07 |
| Normalized Basic EPS | 0.20 | 0.13 | 0.08 | 0.04 | 0.04 |
| EPS Diluted | -0.31 | -0.41 | -0.50 | -0.48 | 0.06 |
| Normalized Diluted EPS | 0.19 | 0.13 | 0.08 | 0.04 | 0.04 |
| Average Basic Shares Outstanding | 1.99B | 1.99B | 1.99B | 1.99B | 1.98B |
| Average Diluted Shares Outstanding | 2.02B | 2.01B | 2.00B | 1.99B | 1.99B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |